$REX
REX American Resources Corp Stock $rex

$rex Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000093041324001186 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2024	2023
Revenue	$187.6M	$833.4M	$855.0M
YoY Change	-6.27%	-2.53%	10.35%
Cost Of Revenue	$157.2M	$734.4M	$800.3M
YoY Change	-15.15%	-8.24%	18.25%
Gross Profit	$30.41M	$99.02M	$54.73M
YoY Change	104.11%	80.92%	-44.19%
Gross Profit Margin	16.21%	11.88%	6.4%
Selling, General & Admin	$7.383M	$29.38M	$28.96M
YoY Change	9.88%	1.46%	1.69%
% of Gross Profit	24.28%	29.67%	52.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.423M	$17.79M	$17.98M
YoY Change	-1.12%	-1.01%	-0.31%
% of Gross Profit	14.54%	17.97%	32.84%
Operating Expenses	$7.383M	$29.38M	$28.96M
YoY Change	9.88%	1.46%	1.69%
Operating Profit	$23.03M	$69.64M	$25.78M
YoY Change	181.5%	170.18%	-62.96%
Interest Expense	$4.646M	$13.92M	$8.745M
YoY Change	83.27%	59.19%	32.02%
% of Operating Profit	20.18%	19.99%	33.93%
Other Income/Expense, Net	$4.789M	$15.72M	$12.96M
YoY Change	82.72%	21.34%	9868.46%
Pretax Income	$32.46M	$98.48M	$47.48M
YoY Change	143.42%	107.43%	-37.39%
Income Tax	$7.164M	$22.56M	$9.542M
% Of Pretax Income	22.07%	22.91%	20.1%
Net Earnings	$20.57M	$60.94M	$27.70M
YoY Change	152.03%	120.01%	-47.11%
Net Earnings / Revenue	10.96%	7.31%	3.24%
Basic Earnings Per Share		$3.49	$1.57
Diluted Earnings Per Share	$1.15	$3.47	$1.57
COMMON SHARES
Basic Shares Outstanding	17.50M shares	17.48M shares	17.64M shares
Diluted Shares Outstanding		17.58M shares	17.64M shares

Balance Sheet

Concept	2024 Q1	2024	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$378.7M	$378.7M	$280.9M
YoY Change	34.78%	34.78%	9.86%
Cash & Equivalents	$223.4M	$223.4M	$69.61M
Short-Term Investments	$155.3M	$155.3M	$211.3M
Other Short-Term Assets	$17.55M	$17.55M	$14.83M
YoY Change	18.31%	18.31%	0.76%
Inventory	$26.98M	$26.98M	$48.74M
Prepaid Expenses
Receivables	$23.19M	$23.19M	$25.16M
Other Receivables	$5.728M	$5.728M	$2.962M
Total Short-Term Assets	$452.1M	$452.1M	$372.6M
YoY Change	21.32%	21.32%	7.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$168.6M	$168.6M	$150.7M
YoY Change	24.45%	11.89%	1.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$34.94M	$34.94M	$33.05M
YoY Change	5.72%	5.72%	8.11%
Other Assets	$9.138M	$9.138M	$23.18M
YoY Change	-60.58%	-60.58%	-10.34%
Total Long-Term Assets	$212.7M	$212.7M	$206.9M
YoY Change	2.79%	2.79%	0.85%
TOTAL ASSETS
Total Short-Term Assets	$452.1M	$452.1M	$372.6M
Total Long-Term Assets	$212.7M	$212.7M	$206.9M
Total Assets	$664.8M	$664.8M	$579.6M
YoY Change	14.7%	14.7%	5.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$42.07M	$42.07M	$34.09M
YoY Change	23.41%	23.41%	5.66%
Accrued Expenses	$23.38M	$23.38M	$20.51M
YoY Change	52.56%	14.02%	19.31%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$66.26M	$66.26M	$54.60M
YoY Change	21.36%	21.36%	8.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$9.348M	$9.348M	$12.89M
YoY Change	208.11%	-27.47%	40.34%
Total Long-Term Liabilities	$9.348M	$9.348M	$12.89M
YoY Change	-33.16%	-27.47%	40.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$66.26M	$66.26M	$54.60M
Total Long-Term Liabilities	$9.348M	$9.348M	$12.89M
Total Liabilities	$150.9M	$150.9M	$131.6M
YoY Change	120.0%	14.66%	10.06%
SHAREHOLDERS EQUITY
Retained Earnings	$701.8M
YoY Change	9.51%
Common Stock	$4.068M
YoY Change	363.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$191.9M
YoY Change	-0.93%
Treasury Stock Shares
Shareholders Equity	$513.9M	$513.9M	$448.0M
YoY Change
Total Liabilities & Shareholders Equity	$664.8M	$664.8M	$579.6M
YoY Change	14.7%	14.7%	5.31%

Cashflow Statement

Concept	2024 Q1	2024	2023
OPERATING ACTIVITIES
Net Income	$20.57M	$60.94M	$27.70M
YoY Change	152.03%	120.01%	-47.11%
Depreciation, Depletion And Amortization	$4.423M	$17.79M	$17.98M
YoY Change	-1.12%	-1.01%	-0.31%
Cash From Operating Activities	$60.78M	$128.0M	$54.80M
YoY Change	7487.77%	133.54%	-40.25%
INVESTING ACTIVITIES
Capital Expenditures	$15.30M	$37.66M	$15.58M
YoY Change	82.28%	141.77%	-403.9%
Acquisitions
YoY Change
Other Investing Activities	$107.0M	$66.07M	-$182.9M
YoY Change	-290.73%	-136.12%	-1855.56%
Cash From Investing Activities	$91.67M	$28.40M	-$198.5M
YoY Change	-242.16%	-114.31%	-3849.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$13.01M
YoY Change		-100.0%	-296.35%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.606M	-4.322M	-$17.01M
YoY Change	59.06%	-74.59%	53.3%
NET CHANGE
Cash From Operating Activities	60.78M	128.0M	$54.80M
Cash From Investing Activities	91.67M	28.40M	-$198.5M
Cash From Financing Activities	-3.606M	-4.322M	-$17.01M
Net Change In Cash	148.8M	152.1M	-$160.7M
YoY Change	-325.7%	-194.6%	-287.08%
FREE CASH FLOW
Cash From Operating Activities	$60.78M	$128.0M	$54.80M
Capital Expenditures	$15.30M	$37.66M	$15.58M
Free Cash Flow	$45.47M	$90.31M	$39.22M
YoY Change	-698.74%	130.28%	-59.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	400000	usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-01-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2024	dei	Entity File Number EntityFileNumber	001-09097
CY2024	dei	Entity Registrant Name EntityRegistrantName	REX AMERICAN RESOURCES CORPORATION
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	31-1095548
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	7720 Paragon Road
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Dayton
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	45459
CY2024	dei	City Area Code CityAreaCode	937
CY2024	dei	Local Phone Number LocalPhoneNumber	276-3931
CY2024	dei	Security12b Title Security12bTitle	Common Stock, $.01 par valueREXNew York Stock Exchange
CY2024	dei	Trading Symbol TradingSymbol	REX
CY2024	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	false
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	565698474	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17503745	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	223397000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69612000	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	155260000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	211331000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1735000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23185000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25162000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	26984000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	48744000	usd
CY2024Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5728000	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2962000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17549000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13098000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	452103000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	372644000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	155587000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	135497000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13038000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15214000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9138000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23179000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	34936000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	33045000	usd
CY2024Q1	us-gaap	Assets Assets	664802000	usd
CY2023Q1	us-gaap	Assets Assets	579579000	usd
CY2024Q1	rex	Accounts Payable Trade Related Parties AccountsPayableTradeRelatedParties	5800000	usd
CY2023Q1	rex	Accounts Payable Trade Related Parties AccountsPayableTradeRelatedParties	1500000	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	42073000	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	34091000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4469000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5180000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19717000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15328000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	66259000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	54599000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1598000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1097000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8378000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9855000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	970000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3034000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10946000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	13986000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29853000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29853000	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	299000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	299000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3769000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	578000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	701761000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	640826000	usd
CY2024Q1	rex	Treasury Stock Shares1 TreasuryStockShares1	12350000	shares
CY2023Q1	rex	Treasury Stock Shares1 TreasuryStockShares1	12463000	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	191911000	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	193721000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	513918000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	447982000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	73679000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	63012000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	587597000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	510994000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	664802000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	579579000	usd
CY2024	us-gaap	Revenues Revenues	833384000	usd
CY2023	us-gaap	Revenues Revenues	855000000	usd
CY2022	us-gaap	Revenues Revenues	774802000	usd
CY2024	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	117000000	usd
CY2023	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	135400000	usd
CY2022	us-gaap	Related Parties Amount In Cost Of Sales RelatedPartiesAmountInCostOfSales	90200000	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	735166000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	806398000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	684173000	usd
CY2024	us-gaap	Gross Profit GrossProfit	98218000	usd
CY2023	us-gaap	Gross Profit GrossProfit	48602000	usd
CY2022	us-gaap	Gross Profit GrossProfit	90629000	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	29379000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22827000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	21545000	usd
CY2024	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	13921000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8745000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6624000	usd
CY2024	us-gaap	Interest And Other Income InterestAndOtherIncome	15724000	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	12959000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	130000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	98484000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	47479000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	75838000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22560000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9542000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19031000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	75924000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	37937000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	56807000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	14989000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	10240000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	9235000	usd
CY2024	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	60935000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	27697000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	47572000	usd
CY2022	rex	Net Income From Discontinued Operations Net Of Tax Related Parties NetIncomeFromDiscontinuedOperationsNetOfTaxRelatedParties	300000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	4395000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-397000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4792000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	60935000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	27697000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	52364000	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17482000	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17638000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17946000	shares
CY2024	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	3.49
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.57
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.65
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.27
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.49
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.57
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.92
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17576000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17638000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17946000	shares
CY2024	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	3.47
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.57
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.65
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.27
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	3.47
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.57
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.92
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	437183000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	61202000	usd
CY2022	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	304000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	6627000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	4772000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	272000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	487562000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	37937000	usd
CY2023	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	13012000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	3998000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2505000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	510994000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	75924000	usd
CY2024	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	22000	usd
CY2024	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	4344000	usd
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5001000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	587597000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	75924000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	37937000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	61202000	usd
CY2022	rex	Net Income From Discontinued Operations Net Of Tax NetIncomeFromDiscontinuedOperationsNetOfTax	-4395000	usd
CY2024	rex	Net Income From Continuing Operations NetIncomeFromContinuingOperations	75924000	usd
CY2023	rex	Net Income From Continuing Operations NetIncomeFromContinuingOperations	37937000	usd
CY2022	rex	Net Income From Continuing Operations NetIncomeFromContinuingOperations	56807000	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17794000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17976000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18031000	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5245000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5328000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5560000	usd
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6209000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1930000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1753000	usd
CY2024	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	13921000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8745000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	6624000	usd
CY2024	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	12030000	usd
CY2023	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	6266000	usd
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5514000	usd
CY2024	us-gaap	Investment Income Interest InvestmentIncomeInterest	10008000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	2839000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	43000	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-243000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	102000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-30000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	14627000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	915000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	12730000	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1977000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-659000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6108000	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-21760000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6519000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4799000	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4495000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	452000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-199000	usd
CY2024	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	2766000	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-3715000	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	1103000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	7868000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1478000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	16005000	usd
CY2024	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-4517000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2752000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	475000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	127970000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	54795000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	98427000	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-6716000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	127970000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	54795000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	135497000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	91711000	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37663000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15578000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5126000	usd
CY2024	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	448507000	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	399350000	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	88949000	usd
CY2024	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	514586000	usd
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	216735000	usd
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	99309000	usd
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	29000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	60000	usd
CY2024	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	43000	usd
CY2023	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	319000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	28402000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-198507000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5294000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13012000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6627000	usd
CY2024	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	22000	usd
CY2024	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-4344000	usd
CY2023	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-3997000	usd
CY2022	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-4772000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-4322000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-17009000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-11399000	usd
CY2022	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	304000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4322000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17009000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11095000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	152050000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-160721000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	85910000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71347000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232068000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146158000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	223397000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71347000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232068000	usd
CY2024	rex	Non Cash Financing Activities Equity Awards Issued NonCashFinancingActivitiesEquityAwardsIssued	965000	usd
CY2023	rex	Non Cash Financing Activities Equity Awards Issued NonCashFinancingActivitiesEquityAwardsIssued	1539000	usd
CY2022	rex	Non Cash Financing Activities Equity Awards Issued NonCashFinancingActivitiesEquityAwardsIssued	100000	usd
CY2024	rex	Non Cash Financing Activities Equity Awards Accrued NonCashFinancingActivitiesEquityAwardsAccrued	2172000	usd
CY2023	rex	Non Cash Financing Activities Equity Awards Accrued NonCashFinancingActivitiesEquityAwardsAccrued	965000	usd
CY2022	rex	Non Cash Financing Activities Equity Awards Accrued NonCashFinancingActivitiesEquityAwardsAccrued	1580000	usd
CY2024	rex	Non Cash Investing Activities Accrued Capital Expenditures NonCashInvestingActivitiesAccruedCapitalExpenditures	918000	usd
CY2023	rex	Non Cash Investing Activities Accrued Capital Expenditures NonCashInvestingActivitiesAccruedCapitalExpenditures	425000	usd
CY2022	rex	Non Cash Investing Activities Accrued Capital Expenditures NonCashInvestingActivitiesAccruedCapitalExpenditures	78000	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3210000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	9321000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4103000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	223397000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1735000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	2222000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	223397000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71347000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69612000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	229846000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	232068000	usd
CY2024	rex	Number Of Operating Entities NumberOfOperatingEntities	3	pure
CY2024	us-gaap	Fiscal Period FiscalPeriod	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: justify"><b><i>Fiscal Year – </i></b>All references in these consolidated financial statements to a particular fiscal year are to the Company’s fiscal year ended January 31. The Company refers to its fiscal year by reference to the year immediately preceding the January 31 fiscal year end date. For example, “fiscal year 2023” means the period February 1, 2023 to January 31, 2024.</p>
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: justify"><b><i>Use of Estimates – </i></b>The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: justify"><b><i>Concentrations of Risk </i></b><i>–</i>The Company maintains cash and cash equivalents in accounts with financial institutions which exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company does not believe there is significant credit risk related to its cash and cash equivalents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: justify">The Company sells its products to a limited number of larger commercial buyers, which may increase the chance of loss due to non-performance by a counterparty.<i> </i>Nine (fiscal year 2023), eight (fiscal year</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: justify">2022), and nine (fiscal year 2021) customers accounted for approximately 92%, 90%, and 85% of the Company’s net sales and revenue during fiscal years 2023, 2022, and 2021, respectively. At January 31, 2024 and 2023, six and four customers represented approximately 93% and 81%, respectively, of the Company’s accounts receivable balance. The Company has not experienced any significant losses in such accounts.</p>
CY2024	rex	Concentration Risk Number Of Customers ConcentrationRiskNumberOfCustomers	9	pure
CY2023	rex	Concentration Risk Number Of Customers ConcentrationRiskNumberOfCustomers	8	pure
CY2022	rex	Concentration Risk Number Of Customers ConcentrationRiskNumberOfCustomers	9	pure
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10255000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	400873000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	363821000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	245286000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	228324000	usd
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	800000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	700000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	9102000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12695000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5299000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10194000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12583000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	25855000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	26984000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	48744000	usd
CY2024Q1	us-gaap	Land And Land Improvements LandAndLandImprovements	32403000	usd
CY2023Q1	us-gaap	Land And Land Improvements LandAndLandImprovements	30194000	usd
CY2024Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	23810000	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	23707000	usd
CY2024Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	307326000	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	299665000	usd
CY2024Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	37334000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	155587000	usd
CY2024	us-gaap	Depreciation Depreciation	17800000	usd
CY2023	us-gaap	Depreciation Depreciation	18000000	usd
CY2022	us-gaap	Depreciation Depreciation	18000000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	806398000	usd
CY2023	us-gaap	Gross Profit GrossProfit	48602000	usd
CY2023	rex	Selling General And Administrative Expenses SellingGeneralAndAdministrativeExpenses	-22827000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	684173000	usd
CY2022	us-gaap	Gross Profit GrossProfit	90629000	usd
CY2022	rex	Selling General And Administrative Expenses SellingGeneralAndAdministrativeExpenses	-21545000	usd
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1650000	shares
CY2024	us-gaap	Interest And Fee Income Other Loans InterestAndFeeIncomeOtherLoans	1000000	usd
CY2023	us-gaap	Interest And Fee Income Other Loans InterestAndFeeIncomeOtherLoans	7800000	usd
CY2024	us-gaap	Revenues Revenues	833384000	usd
CY2023	us-gaap	Revenues Revenues	855000000	usd
CY2022	us-gaap	Revenues Revenues	774802000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	34936000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	33045000	usd
CY2024Q1	rex	Forward Purchase Contracts Asset ForwardPurchaseContractsAsset	579000	usd
CY2024Q1	rex	Forward Purchase Contracts Liability ForwardPurchaseContractsLiability	-802000	usd
CY2024Q1	rex	Commodity Futures In A Loss Position CommodityFuturesInALossPosition	-297000	usd
CY2024Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	1099000	usd
CY2023Q1	rex	Forward Purchase Contracts Asset ForwardPurchaseContractsAsset	105000	usd
CY2023Q1	rex	Commodity Futures In A Gain Position CommodityFuturesInAGainPosition	80000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	185000	usd
CY2023Q1	rex	Forward Purchase Contracts Liability ForwardPurchaseContractsLiability	-355000	usd
CY2023Q1	rex	Commodity Futures In A Loss Position CommodityFuturesInALossPosition	-67000	usd
CY2023Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	422000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	7837000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	21964000	usd
CY2024Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1301000	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1215000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0594	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0551	pure
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9138000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	23179000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9457000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4428000	usd
CY2024Q1	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	3373000	usd
CY2023Q1	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	4116000	usd
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2972000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1311000	usd
CY2023Q1	rex	Commodity Futures CommodityFutures	67000	usd
CY2024Q1	rex	Forward Purchase Contracts ForwardPurchaseContracts	802000	usd
CY2023Q1	rex	Forward Purchase Contracts ForwardPurchaseContracts	355000	usd
CY2024Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1742000	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1850000	usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	2049000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1371000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1152000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	19717000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15328000	usd
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	6386000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	7360000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	6346000	usd
CY2024	us-gaap	Variable Lease Cost VariableLeaseCost	301000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	399000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	1907000	usd
CY2024	us-gaap	Lease Cost LeaseCost	6687000	usd
CY2023	us-gaap	Lease Cost LeaseCost	7759000	usd
CY2022	us-gaap	Lease Cost LeaseCost	8253000	usd
CY2023	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	2	pure
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	472000	shares
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	252000	shares
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	13000000	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6600000	usd
CY2024Q1	rex	Stock Repurchase Program Number Of Additional Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased	877000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29853000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29853000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17504000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17390000	shares
CY2024Q1	rex	Asset Derivatives Net Position With Broker AssetDerivativesNetPositionWithBroker	1855000	usd
CY2023Q1	rex	Asset Derivatives Net Position With Broker AssetDerivativesNetPositionWithBroker	1815000	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	2434000	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	1920000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	802000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	422000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	2152000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	2152000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	1735000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	1735000	usd
CY2024	rex	Net Sales NetSales	-37000	usd
CY2023	rex	Net Sales NetSales	-1024000	usd
CY2022	rex	Net Sales NetSales	-12109000	usd
CY2024	rex	Cost Of Sales CostOfSales	15023000	usd
CY2023	rex	Cost Of Sales CostOfSales	-12714000	usd
CY2022	rex	Cost Of Sales CostOfSales	-3427000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	453000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	450000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	21778	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	81264	shares
CY2023Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	2320000	usd
CY2023Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Non Vested In Period Weighted Average Remaing Vesting Term ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonVestedInPeriodWeightedAverageRemaingVestingTerm	P2Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	113726	shares
CY2024	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionVestedInPeriodWeightedAverageGrantDateFairValue	3945000	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	32135	shares
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	896000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	162855	shares
CY2024Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	5369000	usd
CY2024Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Non Vested In Period Weighted Average Remaing Vesting Term ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonVestedInPeriodWeightedAverageRemaingVestingTerm	P2Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	30167	shares
CY2022Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	773000	usd
CY2022Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Non Vested In Period Weighted Average Remaing Vesting Term ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonVestedInPeriodWeightedAverageRemaingVestingTerm	P1Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	70689	shares
CY2023	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionVestedInPeriodWeightedAverageGrantDateFairValue	2032000	usd
CY2023	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	450	shares
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	13000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	19142	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	472000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	81264	shares
CY2023Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	2320000	usd
CY2023Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Non Vested In Period Weighted Average Remaing Vesting Term ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonVestedInPeriodWeightedAverageRemaingVestingTerm	P2Y
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	59102	shares
CY2021Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	1398000	usd
CY2021Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Non Vested In Period Weighted Average Remaing Vesting Term ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonVestedInPeriodWeightedAverageRemaingVestingTerm	P1Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8409	shares
CY2022	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionVestedInPeriodWeightedAverageGrantDateFairValue	275000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	37344	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	900000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	30167	shares
CY2022Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageGrantDateFairValue	773000	usd
CY2022Q1	rex	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Non Vested In Period Weighted Average Remaing Vesting Term ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionNonVestedInPeriodWeightedAverageRemaingVestingTerm	P1Y
CY2023	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	67500	shares
CY2023Q1	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	2700000	usd
CY2024	us-gaap	Restricted Stock Expense RestrictedStockExpense	1100000	usd
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	700000	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17482000	shares
CY2024	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	94000	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17576000	shares
CY2024Q1	rex	Forward Purchase Contracts Quantity ForwardPurchaseContractsQuantity	17400000	bu
CY2024Q1	rex	Quantity Of Natural Gas Under Sales Commitmen QuantityOfNaturalGasUnderSalesCommitmen	1.9	mmbtu
CY2024	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	34900000	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4580000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4485000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4450000	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	14102000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2925000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	12064000	usd
CY2024	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	18682000	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	7410000	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	16514000	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3377000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	4167000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3098000	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	501000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2035000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-581000	usd
CY2024	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	3878000	usd
CY2023	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	2132000	usd
CY2022	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	2517000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22560000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9542000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19031000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	12296000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	26061000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	611000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	627000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	202000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	244000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	288000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	240000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	160000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	192000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13237000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	26980000	usd
CY2024Q1	rex	Deferred Tax Liabilities Basis In Pass Through Entities Including Depreciation DeferredTaxLiabilitiesBasisInPassThroughEntitiesIncludingDepreciation	6334000	usd
CY2023Q1	rex	Deferred Tax Liabilities Basis In Pass Through Entities Including Depreciation DeferredTaxLiabilitiesBasisInPassThroughEntitiesIncludingDepreciation	5821000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	664000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	292000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6998000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6113000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	6239000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	20867000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	12300000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	26100000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	160000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	192000	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	32000	usd
CY2022Q1	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	11300000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	400000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	-3000000	usd
CY2024	us-gaap	Income Taxes Paid IncomeTaxesPaid	12730000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	2795000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	7239000	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	20682000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	9971000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	15926000	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3299000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1725000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2396000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2542000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	5184000	usd
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2150000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	508000	usd
CY2024	rex	Effective Income Tax Reconciliation Uncertain Tax Position EffectiveIncomeTaxReconciliationUncertainTaxPosition	-98000	usd
CY2023	rex	Effective Income Tax Reconciliation Uncertain Tax Position EffectiveIncomeTaxReconciliationUncertainTaxPosition	2281000	usd
CY2022	rex	Effective Income Tax Reconciliation Uncertain Tax Position EffectiveIncomeTaxReconciliationUncertainTaxPosition	8340000	usd
CY2024	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	3650000	usd
CY2023	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	2523000	usd
CY2022	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	2231000	usd
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	177000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	122000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-216000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22560000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9542000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19031000	usd
CY2024Q1	rex	Unrecognized Tax Benefits Without Accrued Penalties And Interest UnrecognizedTaxBenefitsWithoutAccruedPenaltiesAndInterest	18895000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	70000	usd
CY2024	rex	Increase Decrease In Provision For Income Taxes IncreaseDecreaseInProvisionForIncomeTaxes	-18812000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	19088000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	16781000	usd
CY2024	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	45000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	165000	usd
CY2024	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-168000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	2142000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18965000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	19088000	usd
CY2024	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<table cellpadding="0" cellspacing="0" style="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif"> <td style="width: 0%; font: 10pt Times New Roman, Times, Serif"></td><td style="width: 24pt; font: 10pt Times New Roman, Times, Serif"><b>13.</b></td><td style="font: 10pt Times New Roman, Times, Serif"><b>CONTINGENCIES</b></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">The Company is involved in various legal actions arising in the normal course of business. After taking into consideration legal counsels’ evaluation of such actions, management is of the opinion that their outcome will not have a material effect on the Company’s consolidated financial statements. There were no liabilities recorded at January 31, 2024 as the Company did not believe that there was a probable and reasonably estimable loss associated with any legal contingencies.</p>
CY2022	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	8602000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	-8202000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation General And Administrative Expense DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense	698000	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-8900000	usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-13295000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	4395000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-397000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4792000	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	300000	usd
CY2024	dei	Auditor Name AuditorName	RSM US LLP
CY2024	dei	Auditor Location AuditorLocation	Des Moines, Iowa
CY2024	dei	Auditor Firm AuditorFirmId	49
CY2024	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest		usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest		usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity		usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity		usd
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2024	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2024	rex	Net Income From Discontinued Operations Net Of Tax NetIncomeFromDiscontinuedOperationsNetOfTax		usd
CY2023	rex	Net Income From Discontinued Operations Net Of Tax NetIncomeFromDiscontinuedOperationsNetOfTax		usd
CY2024	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
CY2022	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits		usd
CY2024	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates		usd
CY2022	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates		usd
CY2024	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations		usd
CY2023	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations		usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2024Q1	rex	Commodity Futures CommodityFutures		usd
CY2024Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes		usd
CY2024Q1	rex	Liability Derivatives Net Position With Broker LiabilityDerivativesNetPositionWithBroker		usd
CY2023Q1	rex	Liability Derivatives Net Position With Broker LiabilityDerivativesNetPositionWithBroker		usd
CY2024	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited		shares
CY2024	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited		shares
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2024	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch		usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0000744187

Files In Submission

Name	View Source	Status
0000930413-24-001186-index-headers.html	Edgar Link	pending
0000930413-24-001186-index.html	Edgar Link	pending
0000930413-24-001186.txt	Edgar Link	pending
0000930413-24-001186-xbrl.zip	Edgar Link	pending
c108550_10k-ixbrl.htm	Edgar Link	pending
c108550_ex21.htm	Edgar Link	pending
c108550_ex23a.htm	Edgar Link	pending
c108550_ex23b.htm	Edgar Link	pending
c108550_ex31.htm	Edgar Link	pending
c108550_ex32.htm	Edgar Link	pending
c108550_ex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
c108550_10k-ixbrl_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rex-20240131.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
x1_c108550a001.jpg	Edgar Link	pending
rex-20240131_def.xml	Edgar Link	unprocessable
rex-20240131_pre.xml	Edgar Link	unprocessable
rex-20240131_cal.xml	Edgar Link	unprocessable
rex-20240131_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REX
REX American Resources Corp Stock $rex

2024 Q1 Form 10-K Financial Statement

#000093041324001186 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REX REX American Resources Corp Stock $rex

2024 Q1 Form 10-K Financial Statement

#000093041324001186 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REX
REX American Resources Corp Stock $rex